In 2024, SIA Swixx Biopharma had revenue of 3 million EUR and profit of 145.8 thousand EUR. The company has 22 employees. Beneficial owners: Dezso Dr. Martha, Laur Saar, Piret Tuul and 1 more.
| year | 2024Latest | 2023 | 2022 |
|---|---|---|---|
Revenue | 3m € -0.1% | 3m € +10.4% | 2,7m € +417.5% |
Profit | 145,8k € +2.8% | 141,8k € +20.8% | 117,4k € +681.8% |
Assets | 785,3k € +33.8% | 586,8k € +48.3% | 395,6k € +194.2% |
Liabilities | 292,4k € +1173.4% | 23k € -18.5% | 28,2k € -52.4% |
Equity | 493k € +42.0% | 347,2k € +80.2% | 192,7k € +155.8% |
Employees | 23 +0.0% | 23 +4.5% | 22 +633.3% |
Overall rating | A+92/100 |
Financial health | 100/100 |
Credit history | 100/100 |
Legal history | 100/100 |
Business activity | 50/100 |
| Overall risk | Low |
No risk flags | |
No tax debts | |
Positive profit | |
Regular report filing | |
| Name, surname | Birth date | Position | Representation rights | Registered | |
|---|---|---|---|---|---|
| - | Board member | Together with at least | |||
| - | Board member | Together with at least | |||
| - | Board member | Together with at least | |||
| - | Board member | Together with at least |
| Name | Changed |
|---|---|
| SIA Amicus Pharma | 10 June 2019 |
| SIA Amicus Pharma | 10 June 2019 |
| SIA Amicus Pharma | 10 June 2019 |
| SIA Amicus Pharma | 10 June 2019 |
| SIA Amicus Pharma | 10 June 2019 |
| SIA Amicus Pharma | 10 June 2019 |
| SIA Amicus Pharma | 10 June 2019 |
| SIA Amicus Pharma | 10 June 2019 |
| SIA Amicus Pharma | 10 June 2019 |
| SIA Amicus Pharma | 10 June 2019 |
| SIA Amicus Pharma | 10 June 2019 |
| SIA Amicus Pharma | 10 June 2019 |
| SIA Amicus Pharma | 10 June 2019 |
| SIA Amicus Pharma | 10 June 2019 |
| SIA Amicus Pharma | 10 June 2019 |
| SIA Amicus Pharma | 10 June 2019 |
| SIA Amicus Pharma | 10 June 2019 |
| SIA Amicus Pharma | 10 June 2019 |
| SIA Amicus Pharma | 10 June 2019 |
| SIA Amicus Pharma | 10 June 2019 |
SIA Swixx Biopharma is located at Rīga, Krišjāņa Valdemāra iela 33A - 8A, LV-1010.
In 2024, SIA Swixx Biopharma had revenue of 2 990 693 EUR and profit of 145 777 EUR. Compared to previous year, revenue decreased by 0.1%. View full financial report →
In 2024, SIA Swixx Biopharma had an average of 22 employees. View tax history →
The beneficial owners of SIA Swixx Biopharma are Dezso Dr. Martha, Laur Saar, Piret Tuul and Rima Jankovska. View ownership details →
Yes, SIA Swixx Biopharma is registered as an active VAT payer with VAT number LV40103845472.
In 2024, the average gross salary at SIA Swixx Biopharma was approximately 4861,13 € per month (net ~ 3371,33 €). This is an approximate calculation. View salary details →
SIA Swixx Biopharma was founded on November 13, 2014. The company has been operating for 12 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 12 years | 164 - 168 | 43% | |
Net revenue | 2 990 693,00 € | 11 - 15 | 95% | |
Profit | 145 777,00 € | 17 - 21 | 94% | |
Equity | 492 993,00 € | 20 - 24 | 90% | |
Assets | 785 347,00 € | 21 - 25 | 92% | |
Fixed assets | 21 650,00 € | - | 90% | |
Investments | 28 193,00 € | - | 90% | |
Liquidity | 2.52 | - | 75% | |
Profitability | 4.9% | - | 10% | |
Registered capital | 2800,00 € | - | 40% |
Annual financial report for 2024.
Annual financial report for 2023.
Annual financial report for 2022.
Annual financial report for 2021.
Annual financial report for 2020.
Annual financial report for 2019.
Registered in the Latvian company register.
| Name, surname | Shares | Ownership rights |
|---|---|---|
| Swixx Biopharma AG | 2800 | 100.00% |
| Name, surname | Nationality | Birth date | |
|---|---|---|---|
| Dezso Dr. Martha | HU | - | |
| Laur Saar | EE | - | |
| Piret Tuul | EE | - | |
| Rima Jankovska | LT | - |